Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2017 (2017), Article ID 6275987, 8 pages
https://doi.org/10.1155/2017/6275987
Research Article

Potential Hepatoprotective Role of Galectin-3 during HCV Infection in End-Stage Renal Disease Patients

1Department of Microbiology, Faculty of Medicine Foca, University of East Sarajevo, Sarajevo, Bosnia and Herzegovina
2Center for Molecular Medicine and Stem Cell Research, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia
3Department of Infectology, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia
4Department of Surgery, Faculty of Medicine Foca, University of East Sarajevo, Sarajevo, Bosnia and Herzegovina

Correspondence should be addressed to Ivan Jovanovic

Received 29 December 2016; Revised 24 February 2017; Accepted 26 February 2017; Published 11 April 2017

Academic Editor: Giuseppe Murdaca

Copyright © 2017 Ruzica Lukic et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Ruzica Lukic, Nevena Gajovic, Ivan Jovanovic, et al., “Potential Hepatoprotective Role of Galectin-3 during HCV Infection in End-Stage Renal Disease Patients,” Disease Markers, vol. 2017, Article ID 6275987, 8 pages, 2017. doi:10.1155/2017/6275987